Researchers Develop New Method to Generate Human Antibodies

News

Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.

Read more

Nanoparticle Delivery of Curcumin Induces Tumor Cell Death

News

Attaching curcumin, a component of the common spice turmeric, to nanoparticles can be used to target and destroy treatment-resistant neuroblastoma tumor cells

Read more

Improving Cells through Gene Editing

Article

The advent of gene editing techniques has generated more excitement in biology and medicine than any discovery since polymerase chain reaction thirty years ago. By allowing the removal or addition of nearly any gene into any cell, gene editing circumvents tedious, lengthy development of cell lines for research and biomanufacturing.

Read more
Edith Heard Unanimously Selected as Next Director General of EMBL

Edith Heard Unanimously Selected as Next Director General of EMBL

News

At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.

Read more
 
Shedding Light on How Tumors Become Resistant to Immunotherapy
News

Researchers have now found that in skin cutaneous melanoma an epigenetic control protein is key to the development of immunotherapy resistance.

Read more

The Role of Lung Cell Turnover in Influenza Pneumonia
News

Research led by University of Cincinnati scientists is investigating how influenza spreads through the lungs by focusing on how resistant or susceptible cells lining the airway are to viral infection.

Read more

Ingestible Drug-Delivery Materials May Improve Patient Treatment Compliance
News

Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.

Read more